by What is the Blood Group Typing Market Size in 2026?
The global blood group typing market size was calculated at USD 2.42 billion in 2025 and is predicted to increase from USD 2.63 billion in 2026 to approximately USD 5.52 billion by 2035, expanding at a CAGR of 8.60% from 2026 to 2035. The market is driven by the rising demand for safe transfusions and advanced blood typing technologies.
Key Takeaways
- North America dominated the market with a 38% share in 2025.
- By region, Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
- By product, the kits segment held a dominant position in the market with a share of 48% in 2025.
- By product, the instruments segment is expected to grow at the fastest CAGR of 7.4% in the market between 2026 and 2035.
- By technology, the serological/immunohematology segment held the largest market share of 52% in 2025.
- By technology, the molecular/genotyping segment is expected to grow with the highest CAGR of 7.6% in the market during the studied years.
- By end user, the hospitals & clinics segment led the global market with a share of 44% in 2025.
- By end user, the diagnostic laboratories segment is expected to expand rapidly in the market with a CAGR of 7.8% in the coming years.
- By application, the transfusion segment registered its dominance in the global market with a share of 45% in 2025.
- By application, the research & drug development segment is expected to grow at a CAGR of 8.0% over the forecast period.
Market Overview
Blood group typing is the technology and systems by which the blood type of an individual is determined, most commonly by the ABO and Rh systems. The market comprises different methodologies, which include serological tests, molecular techniques, and automated platforms, all of which are expected to provide high accuracy, speed, and reliability in blood typing. The market is expanding rapidly due to the rising demand for blood transfusions, the growing rate of chronic diseases, including anemia and cancer, and the development of automated blood typing systems that simplify laboratory processes. The growth of healthcare infrastructure, increasing awareness of safe transfusion, and the increasing number of hospitals, blood banks , and diagnostic laboratories contribute to market growth. Blood typing is critical in hospitals, blood banks, and diagnostic laboratories.
How is AI Influencing the Blood Group Typing Market?
The blood group typing market is transforming with the rise of artificial intelligence, which is enhancing blood typing processes with greater accuracy, efficiency, and scalability. Complex serological and molecular data are being processed automatically with the help of AI-based algorithms to minimize the possibility of human error and confirm that such antigens as ABO and Rh, among other rare antigens, are properly identified. AI systems can process high sample throughput in a short duration of time; hence, they can accommodate high-throughput hospital laboratories and blood banks. Furthermore, integration of AI enables connection to all the information management systems of laboratories and hospital databases, which is required to manage data in real-time, trace data, and comply with any regulatory needs.
Blood Group Typing Market Trends
- Hospitals and blood banks are increasingly adopting computerized systems, which reduce manual errors, improve throughput, and enable high-precision testing in high-volume clinical and transfusion settings.
- Molecular techniques are gaining popularity due to their ability to detect rare and complex blood group antigens, offering higher accuracy than traditional serological methods, especially for patients with multiple transfusions.
- Laboratory Information Management Systems (LIMS) and other digital health platforms are being integrated with blood typing systems, enhancing workflow efficiency, traceability, and fluid management in clinical diagnostics and blood banks.
- Advanced blood typing technologies are gaining traction in the Asia-Pacific, Latin American, and Middle Eastern regions, driven by expanding healthcare infrastructure, increased awareness of safe transfusion practices, and growth in hospital networks.
- There is growing use of molecular methods like PCR based assays, microarrays, and next generation sequencing (NGS) to detect rare or complex blood group antigens that traditional serology may miss. These offer higher accuracy, especially for chronically transfused or prenatal patients.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 2.42 Billion |
| Market Size in 2026 | USD 2.63 Billion |
| Market Size by 2035 | USD 5.52 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 8.60% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product, Technology, End User, Application, and region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Regional Insights
North America Blood Group Typing Market Size and Growth 2026 to 2035
The North America blood group typing market size is estimated at USD 919.60 million in 2025 and is projected to reach approximately USD 2,125.20 million by 2035, with a 8.74% CAGR from 2026 to 2035.
Why Did North America Lead the Global Blood Group Typing Market?
North America dominated the global blood group typing market with a major share of 38% in 2025, driven by its developed healthcare infrastructure, high adoption of advanced diagnostic technologies, and favorable regulatory environment. Market growth is further supported by the rising prevalence of chronic diseases, increasing demand for blood transfusions, and growing awareness of transfusion safety. Additionally, strong investments in research and development enable rapid implementation of automated, molecular, and AI-assisted blood typing technologies, while hospitals and laboratories benefit from efficient testing solutions supported by favorable reimbursement policies and well-structured healthcare systems.
U.S. Blood Group Typing Market Size and Growth 2026 to 2035
The U.S. blood group typing market size is calculated at USD 689.70 million in 2025 and is expected to reach nearly USD 1,604.53 million in 2035, accelerating at a strong CAGR of 8.81% between 2026 and 2035.
U.S. Market Analysis
The U.S. is the major contributor to the North American blood group typing market. This is because the country has an advanced healthcare infrastructure with widespread adoption of automated and molecular blood typing systems in hospitals and diagnostic laboratories. There is a high demand for safe blood transfusions, driven by increasing surgeries, chronic disease prevalence, trauma care, and cancer treatments. Regulatory focus on patient safety and standardized testing, along with investments in digital health solutions, AI-enabled diagnostics, and laboratory modernization, is further accelerating market growth.
Why is Asia Pacific Experiencing the Fastest Growth in the Blood Group Typing Market?
Asia Pacific is expected to grow at the fastest CAGR during the forecast period, owing to the increasing healthcare investments, rising prevalence of chronic diseases, and the expansion of hospitals and diagnostic facilities. Rapid economic growth in countries such as China, India, and Japan has enabled the adoption of modern blood typing technologies, including automated and molecular systems. Market growth is further supported by greater awareness of safe transfusions, rising demand for organ transplants, and increased blood donations, while advanced blood typing systems are becoming more accessible in emerging markets through partnerships with international equipment manufacturers.
Blood Group Typing Market Companies
- Abbott Laboratories
- Bio-Rad Laboratories
- Ortho Clinical Diagnostics
- Grifols S.A.
- Immucor Inc.
- Siemens Healthineers
- Terumo Corporation
- Quotient Limited
- DIAGAST
- Rockwell Automation
- Werfen
- Fujirebio
- Macopharma
- Haemonetics Corporation
- Blutest AG
Recent Developments
- In June 2025, Devyser introduced Devyser Genomic Blood Typing, a solution based on NGS that allows the full methodology of molecular blood type. The all-in-one assay includes a red blood cell (RBC), human platelet antigen (HPA), and human neutrophil antigen (HNA) in a single streamlined assay.(Source: https://devyser.com )
- In May 2024, Thermo Fisher Scientific released the Applied Biosystems Axiom BloodGenomiX Array and Software to make blood genotyping more precise in clinical research. Useful in based on HLA and platelet (HPA) types, the high-throughput array can detect more than 40 genes and 260 antigens in one assay and in over 38 blood group systems(Source: https://www.businesswire.com )
Segments Covered in the Report
By Product
- Kits
- Instruments
- Software & Services
By Technology
- Serological/Immunohematology
- Molecular/Genotyping
- Microarray & Others
By End User
- Hospitals & Clinics
- Blood Banks
- Diagnostic Laboratories
- Research Institutes
By Application
- Transfusion
- Organ & Tissue Transplant
- Research & Drug Development
- Paternity Testing & Forensics
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
Check this Report too: Rigless Intervention Services Market
Get Sample : https://www.precedenceresearch.com/sample/8146
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7623
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344
